Novel Hepatitis C Treatments Impact HCC Care: Q&A With Michael P. Manns, MD
Novel agents that target the replication of the hepatitis C virus are poised to have a far-reaching impact on the prevention and recurrence of hepatocellular carcinoma (HCC).